Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |